IGF-I receptor signalling: lessons from the somatotroph

Area of Science:

• Endocrinology
• Molecular Biology
• Cell Signaling

Background:

• Insulin-like growth factor 1 (IGF-I) is a key regulator of pituitary growth hormone (GH) secretion.
• IGF-I acts on both the hypothalamus and pituitary, with autocrine and endocrine roles in GH regulation.
• IGF-I signaling inhibits GH gene transcription and secretion.

Purpose of the Study:

• To investigate the structure-function relationship of the human IGF-I receptor in GH-secreting pituitary cells.
• To elucidate the specific mechanisms by which IGF-I mediates negative feedback on GH secretion.
• To identify critical domains within the IGF-I receptor for signal transduction to the GH gene.

Main Methods:

• Utilized stable GH-secreting transfectants expressing wild-type and mutant human IGF-I receptors.
• Performed structure-function studies using kinase-deficient and hybrid receptor models.
• Assessed IGF-I-induced GH secretion, GH mRNA synthesis, and ERK activation.

Main Results:

• The 950Tyr residue on the IGF-I receptor is critical for transducing the inhibitory signal to the GH gene.
• Kinase-deficient human IGF-I receptors exhibited a dominant negative effect, blocking IGF-I-mediated suppression of GH secretion.
• IGF-I receptor activation of ERKs was observed in pituitary cells, indicating downstream signaling pathways.

Conclusions:

• The pituitary IGF-I receptor is essential for mediating the negative feedback regulation of GH secretion.
• IGF-I receptor function is critical for metabolic control of the GH axis and may influence responses to nutritional status.
• Understanding IGF-I receptor mechanisms offers insights into GH axis regulation and potential therapeutic targets for IGF-I-dependent tumors.